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Abstract. We present a new polymerase chain reaction assay based on telomeric sequences of Leishmania don-
ovani. When this assay was used in dilutions of purified L. donovani DNA, a strong amplification signal was observed
with 1 fg of DNA. In a specificity test that used purified DNA from Old World and New World Leishmania, the
assay recognized all parasites isolated from patients with visceral leishmaniasis, except for 2 isolates of Leishmania
colombiensis from Venezuela and 1 isolate from Brazil. All Leishmania major and Leishmania tropica isolates tested
were negative, except for one isolate in each species. We also used the assay on fresh and archive bone marrow
samples recovered from Giemsa-stained slides and from dried blood stains.
INTRODUCTION
Visceral leishmaniasis (VL) is a widespread parasitic dis-
ease caused by the species of the genus Leishmania. In the
Old World, L. donovani is the main etiological agent. How-
ever, in the New World, the identity of the Leishmania spe-
cies causing VL is still being debated.1 Currently, leishman-
iasis is endemic in 82 countries, and nearly 350 million peo-
ple live in areas at risk for acquiring the infection. Official
figures reveal that VL alone accounts for 75,000 deaths an-
nually, with more than half of these occurring in Sudan and
India,2,3 including 50,000 cases of kala-azar in Bihar-India.4
Kala-azar is usually fatal if untreated. The symptoms of fe-
ver and malaise are often confused with those of malaria,
tuberculosis, and other parasitic diseases because the symp-
toms are insufficiently specific for early diagnosis.
Routine diagnosis for VL consists of direct microscopy
on samples from spleen, lymph node, or bone marrow, or
by cell culture. Microscopy, although simple and cheap, may
be risky and of limited sensitivity.5 On the other hand, de-
tection of parasites by cell culture is a time-consuming and
labor-intensive process. An urgent need exists for the de-
velopment and evaluation of more sensitive and specific
methods.
Here, we report the development of a polymerase chain
reaction (PCR) assay that is based on telomeric sequences of
L. donovani and its application to the diagnosis of this parasite
in bone marrow and blood samples of patients with VL.
MATERIALS AND METHODS
Parasite and culture conditions. Old World Leish-
mania strains used for the present work are shown in Table
1 and were provided by Drs. K. P. Chang, Chicago School
of Medicine, and K. Stuart, Seattle Biomedical Research In-
stitute. New World strains came from the sources indicated
in Table 2. Confirmatory identification of nonreference
strains was performed by either isoenzymatic, kinetoplast
DNA (kDNA), or nuclear DNA sequences analyses.6–11 The
methods used for each strain are indicated in Tables 1 and
2. Some strains may not have been typed, although other
isolates from the same sites were confirmed.
Promastigotes of all these strains, except Leishmania don-
ovani AG83, were maintained in M199-10% fetal calf se-
rum; L. donovani AG83 was maintained in M199–30% fetal
calf serum. Subculture was performed at  96 hr, when the
cells reached the stationary phase of growth.
Blood collection and human biopsy samples for PCR.
Blood samples and bone marrow samples of 3 parasitolog-
ically confirmed patients with VL were obtained from the
Sahibganj district of Bihar, India. The Venezuelan human
cases of VL came from endemic areas in Trujillo and Falcon
States, western Venezuela. As noted in Table 3, bone marrow
samples were recovered from archive material collected dur-
ing 1992–1998.
Extraction of DNA from promastigotes. DNA extraction
from a small number of cells (105) was standardized as fol-
lows. The cell pellet of 105 Leishmania promastigotes was
made by centrifugation at 5,000 rpm for 15 min at 4C. The
pellet was washed once in phosphate-buffered saline (PBS;
pH 7.2), resuspended in 100 L of lysis buffer (8% Chelex
[Bio-Rad Laboratories, Hercules, CA], 0.33 mg/mL protein-
ase K), and incubated for 15 min at 65C, then boiled for 10
min in a water bath. The sample was centrifuged at 12,000
rpm for 20 min and the supernatant collected in a fresh tube.
Ten microliters of the DNA sample was then used for PCR.
Extraction of DNA from biopsy samples. Blood or bone
marrow samples were kept at room temperature for 30 min.
The samples were then centrifuged at 1,000 rpm for 1 min,
and the supernatant was collected in a fresh tube. The super-
natant was then centrifuged at 5,000 rpm for 15 min at 4C,
and the pellet was washed twice with PBS (pH 7.2). One
milliliter of cold 0.5% saponin in PBS (pH 7.2) was added to
the pellet. The tube was gently tapped, incubated on ice for
5 min, and then centrifuged at 4,000 rpm for 10 min at 4C.
The pellet was washed with PBS (pH 7.2) and 400 L of
NET buffer (150 mM NaCl, 10 mM ethylenediaminetetraa-
cetic acid [EDTA], 50 mM Tris-HCl, pH 7.5). After the wash,
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TABLE 1
Old World Leishmania species used*
Leishmania species Nomenclature used in text Disease Species/country/year PCR telomere Reference
L. donovani Sm
L. donovani Sc6
L. turinica KXG-2
L. infantum Xu
L. infantum Lu
136
137
138
139
140
VL
VL
CL
CL
CL
MHOM/CN/84
MHOM/CN/86
MRHO/CN/88
MHOM/CN/94
MHOM/CN/93





I,k10
I,k10
I,k10
I,k10
I,k10
L. donovani 921
L. donovani 911
L. infantum KA
L. major DE
L. tropica 1092
141
142
143
144
147
VL
VL
VL
CL
VL
MHOM/CN/92
MHOM/CN/91
MHOM/PK/91
MHOM/PK/88
MHOM/SA/91





I,k10
I,k10
I†
I†
I8
L. tropica 1095
L. major Si-177
L. tropica EP2
L. infantum EP5
L. major EP7
148
149
151
152
153
VL
CL
CL
VL
CL
MHOM/SA/91
MHOM/EG/89
MHOM/TR/93
MHOM/TR/93
MHOM/TR/94





I8
I8
S9,10
S9,10
S9,10
L. infantum EP10
L. donovani S. LAL
154
S. LAL
VL
VL
MCAN/TR/95
MHOM/IN/94/S-Lal


S9,10
I‡
L. donovani LSB51.1 51.1 VL MHOM/SD/00/Khartoum  R
L. infantum LSB7.1 7.1 VL MHOM/MA/67/ITMAP  R
L. donovani LSB51.2 51.2 VL MHOM/SD/00/1S-2D  I§
L. donovani AG83
L. donovani UR6
L. donovani
L. donovani
L. infantum
L. major
AG83
UR6
L0564
L0571
IPT1
Friedlin
VL
VL
VL
VL
VL
CL
MHOM/IN/83AG83
MHOM/IN/78/UR6
MHOM/ET/67/HU3
MHOM/IN/80/DD8
MHOM/TN/80/IPT1
MHOM/IL/81/Friedlin






I‡
I,S‡
R
R
R
R
L. major L0575 CL MHOM/SU/59/Pstrain  R
* CAN  dog; CL  cutaneous leishmaniasis; CN  China; EG  Egypt; ET  Ethiopia; HOM  human; I  isoenzyme; IL  Israel; IN  India; k  kinetoplast DNA; MA  Morocco;
PCR  polymerase chain reaction; PK  Pakistan; R  reference strain; RHO  Rhombomys opinus (great gerbil); S  DNA nuclear sequence; SA  Saudi Arabia; SD  Sudan; SU 
former Soviet Union; TN  Tunisia; TR  Turkey; VL  visceral leishmaniasis.
 in the PCR telomere assay column  detection of a visible amplification product;   no detection of the product.
† Typed and donated by David A. Evans.
‡ Madhubala R, unpublished data.
§ LSB51.2 is a clone line of LSB51.1.
FIGURE 1. Organization of Leishmania donovani telomeric sequences and location of polymerase chain reaction primers. C  capture
oligonucleotide; F  forward primer; R  reverse primer; TAS  telomeric-associated sequences. Hexameric sequences (H) are marked with
black dots, 62 mer (62M) are indicated with black squares, and octamers are underlined (O). The location of RsaI endonuclease cutting
sites is marked by vertical arrows.
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TABLE 2
New World Leishmania species and other Kinetoplastida used*
Species Nomenclature used in text Diseae Specie/country/year
PCR
telomere Reference
Leishmania species
L. chagasi
L. chagasi
L. chagasi
L. chagasi
L. colombiensis
L0580
M6445
M11862
M2682
Chuao
VL
VL
VL
VL
VL
MHOM/BR/74/PP75
MHOM/BR/81/M6445
–
–
MHOM/VE/70/Chuao





R
k†
k†
k†
I7
L. colombiensis
L. brazilensis
L. guyanensis
L. garnhami
L. mexicana
L. amazonensis
Talisman
M2903
L0566
Lby
Bel 21
L0570
VL
CL and MCL
CL and MCL
CL
CL
CL
MCAN/VE/72/Talisman
MHOM/VE/75/M2903
MHOM/BR/75/M4147
MHOM/VE/46/Lby
MHOM/BZ/82/BEL21
MHOM/BR/73/M2269






I7
R
R
S6
R
R
Other Kinetoplastida
Trypanosoma cruzi
Crithidia fasciculata
CL Brener
HS6
Chagas disease
–
–
–
–
–
–
–
* BR  Brazil; BZ  Belize; CAN  dog; CL  cutaneous leishmaniasis; HOM  human; I  isoenzyme; MCL  mucocutaneous leishmaniasis; PCR  polymerase chain reaction; R
 reference strain; S  DNA nuclear sequence; VE  Venezuela; VL  visceral leishmaniasis.
 in the PCR telomere assay column  detection of a visible amplification product;   no detection of the product.
† Guevara P, unpublished data.
FIGURE 2. Southern blot of CHEF-separated chromosomes (chromoblots) of Leishmania and Trypanosoma. Panel A was hybridized with
the forward primer, Panel B with the reverse primer, and Panel C with the hexameric probe (CCCTAA)3. Lane 1, Saccharomyces cerevisiae.
Lane 2, Ld 51.2. Lane 3, Ld 51.1. Lane 4, Lm Friedlin. Lane 5, Lb M2903. Lane 6, La L0570. Lane 7, Cf HS6. Lane 8, Tc CL Brener.
1.25% sarcosyl and 0.25 mg ribonuclease were added. The
sample was incubated 1 hr at 37C, 0.15 mg proteinase K was
added, and the sample was incubated at 50C for 2 hr. The
sample was then extracted with phenol, chloroform, and isoa-
myl alcohol (25:24:1) and precipitated with 1/10 volume of 3
M sodium acetate (pH 5.2) and 2.5 volumes of ethanol. The
pellet was washed with 70% ethanol, dried, and resuspended
in TE (10 mM Tris, pH 8.0, 1 mM EDTA).
Recovery of DNA from bone marrow archive material.
Archive material included dry bone marrow samples stained
with Giemsa and stored at room temperature in cardboard
holders. Stain was removed from slides containing samples
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FIGURE 3. Slot blots to test sensitivity of telomeric probes and Leishmania donovani telomeric polymerase chain reaction (PCR) assay. (A)
Dilutions of L. donovani 51.1 cells and negative controls of Leishmania amazonensis hybridized with digoxigenin-labeled capture oligonucle-
otide. (B) Slot blots of the PCR products performed in dilutions of pure L. donovani 51.1 DNA after hybridization with digoxigenin-labeled
capture oligonucleotide.
with 99% acetic acid, then a wash with 1% acetic acid. Sam-
ples were scraped with a razor blade and resuspended in 100
L of TE buffer. The suspension was incubated with 100
g/mL proteinase K for 15 min at 60C, then heated at 95C
for 30 min. A volume of 5 L of each sample was used for
the PCR assay.
Leishmania donovani telomeric PCR assay. The overall
strategy of the PCR assay used in this work is presented in
Figure 1. The forward 5-CCCCGTCCTGTTGGAG-3
primer anchors were used on the 62-mer sequence (Figure
1B), whereas the reverse primer 5-ACGGTGT-
ACTGGTGTACTGG-3 anchors the beginning of the 62-
mer sequence and continues onto the octamer sequences.
A capture oligonucleotide, 5-CGCTGTGCAAGGAAT-
CAGTG-3, was designed for the detection of PCR products
in hybridization experiments. This last step should be used
in all PCR assays to double-check the assay specificity when
complex samples are examined. Although we never ob-
served any cross-reactivity in our assays, we believe this is
an important practice. Oligonucleotides were purchased from
Operon Technologies Inc. (Alameda, CA).
The PCR was performed with 0.8 M of each forward
and reverse primers, 0.2 mM dNTPs for 35 cycles with 1
min at 63C, 1 min at 72C, and 1 min at 94C. Cycles were
followed by 1 min at 63C and 5 min at 72C.
Agarose gel electrophoresis. The PCR products were de-
tected with a 1% agarose gel, and genomic DNA was run
on 0.7% agarose gel with a 6 V/cm gradient.
Polyacrylamide gel electrophoresis. The PCR-amplified
products of Leishmania associated with visceral cases strains
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FIGURE 4. Agarose gel electrophoresis of Leishmania donovani telomeric polymerase chain reaction products. (A) Ethidium bromide-
stained agarose 0.8% gel. (B) Southern blot of gel in A after hybridization with radioactively labeled capture probe. Lane 1, Leishmania
braziliensis M2903. Lane 2, Leishmania colombiensis Chuao. Lane 3, Leishmania amazonensis L0570. Lane 4, Leishmania donovani strain
141.
were digested with restriction endonuclease RsaI and re-
solved on 6% polyacrylamide gel electrophoresis with 0.5	
tuberculin bacillary emulsion (TBE) buffer at 5 V/cm.
Pulsed field gel electrophoresis. Pulsed field gel electro-
phoresis of L. donovani strains was performed on a CHEF-
DR III System apparatus (Bio-Rad Laboratories). Agarose
blocks were prepared as described previously. A 1% gel was
run with 0.5	 TBE buffer (45 mM Tris-borate, 1 mM
EDTA) at 6 V/cm at 120 separation angle with 60 sec–120
sec switching time for 24 hr. The gel was then stained with
ethidium bromide.
Southern, dot, and slot blots. For Southern blot tests, the
gels were depurinated in 0.25 N HCl for 20 min and soaked
in denaturing buffer (0.4 N NaOH, 0.6 M NaCl) for 45 min
with one change of solution. The DNA was transferred to
Hybond-N (Amersham Pharmacia Biotech Ltd., Paisley,
UK) membrane by capillary action, and the membrane was
ultraviolet cross-linked, dried, and kept for hybridization.
For dot blot, genomic DNA or PCR products were used.
The DNA samples to be loaded were denatured by adding
equal volumes of denaturing buffer (0.5 M NaOH, 0.25 N
NaCl) and incubating at room temperature for 10 min. The
denatured samples were kept on ice and diluted in 0.1	 stan-
dard saline citrate (SSC) (15 mM NaCl, 1.5 mM sodium
citrate), 0.125 N NaOH, such that the final volume of each
sample was 200 L. Hybond-N membrane was soaked in
0.4 M Tris-HCl (pH 7.4) for 5 min and fixed onto the dot
or slot blot apparatus. Samples were loaded in the wells of
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TABLE 3
Venezuelan archive cases of visceral leishmaniasis
Patient no. Sex Age Symptoms at initial presentation to clinic
Bone
marrow
(parasites) Treatment*
Telomeric
PCR
1
2
3
4
5
F
M
M
F
F
18 months
22 years
30 years
24 years
3 years
Fever, anemia, splenomegaly
Fever, anemia, splenomegaly, epistaxis
Fever
Fever, hepatosplenomegaly
Fever, anemia, hepatosplenomegaly





Glucantime
Glucantime
Glucantime
None
Glucantime





6
7
8
9
10
F
F
F
F
F
14 months
8 months
18 months
5 years
5 years
Fever, anemia, hepatosplenomegaly
Fever, anemia, splenomegaly, diarrhea
Fever, hepatosplenomegaly
Fever, hepatosplenomegaly
Fever, hepatosplenomegaly, anorexia





Glucantime
Glucantime
Glucantime
Glucantime
Glucantime





11
12
13
F
M
Dog†
5 months
35 years
–
Fever, hepatosplenomegaly, anorexia
Fever, hepatosplenomegaly
–



None
Glucantime
None



* Glucantime dose: 20 mg/kg for 10 days.
† Dog from the domicile of a patient with visceral leishmaniasis.
 in the PCR assay indicates detection of a visible amplification product;   no product detected.
FIGURE 5. Polyacrilamide gel electrophoresis of Leishmania donovani telomeric polymerase chain reaction products digested with RsaI
endonuclease. Lane 1, 100-bp ladder molecular weight (MW) standard. Lane 2, 1-Kbp ladder MW standard. Lane 3, Ld 51.2. Lane 4, Ld
51.1. Lane 5, Ld LO571. Lane 6, Ld LO564. Lane 7, Li IPT1. Lane 8, Lch M11862. Lane 9, Lch L0580. Lane 10, Ld 51.2 total DNA.
dot or slot blot apparatus for 30 min, and light suction was
applied until the samples drained through the wells. Mem-
branes were washed briefly in neutralizing buffer (0.5 M
NaCl, 0.5 M Tris HCl, pH 7.5), ultraviolet cross-linked and
dried.
Slot blots were performed according to Howard and oth-
ers.12
Labeling of telomeric probes. Octamer, 62-mer, and hex-
amer oligonucleotide probes were labeled with [
-32P] aden-
osine triphosphate, 3,000 Ci/mmol (Amersham Pharmacia)
with T4 polynucleotide kinase.13
Capture oligonucleotide was labeled by synthesizing
dUTP-digoxigenin tails with terminal deoxynucleotidyl
transferase.14
Hybridizations. Hybridizations were carried out in 0.5 M
Na-phosphate pH 7.2, 7% sodium dodecyl sulfate (SDS), 1
mM EDTA, 0.1 mg/mL Escherichia coli tRNA at 65C for
18 hr. After hybridization, filters were washed twice with 40
mM Na-phosphate, 0.1% SDS at room temperature for 15
min, and twice at 65C for 15 min. Hybridization tempera-
tures were 58C for the hexamer probe, 54C for the octamer
probe, and 65C for the 62-mer forward oligonucleotide
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probe. After hybridization, the last wash was at the same
temperature as that used for hybridization.
For digoxigenin-labeled capture probe, hybridization was
carried out in 5	 SSC, 0.1% sodium-N-laurylsarcosinate,
0.02% SDS, and 1% blocking reagent (Boehringer Mann-
heim, Mannheim, Germany) at 58C for 3 hr. After hybrid-
ization, filters were washed at room temperature in 6	 SSC
and 0.1% SDS for 5 min, then washed with 2	 SSC and
0.1% SDS at room temperature for 15 min, and finally at
58C for 15 min. The hybridized probe was detected by
chemiluminescence with Lumi-Phos 530 according to the
manufacturer’s directions (Boehringer Mannheim).
RESULTS
Leishmania donovani telomeres could present the block
(Beck AE, unpublished data)15 structure shown in Figure 1A.
Each block comprises a variable number of hexameric re-
peats, then a variable number of an octameric repeat and a
single 62-mer sequence, in that order. The number of blocks
per chromosome varies.15 When chromoblots from Leish-
mania species or other Kinetoplastida were hybridized with
the oligonucleotide probe derived from the 62-mer sequence
(forward primer), we observed hybridization only with L.
donovani chromosomal bands (Figure 2A, lanes 1 and 2).
Similar results were obtained by a probe (reverse primer,
Figure 1B) anchored on the octameric repeat that overlaps
with the 62-mer sequence (Figure 2B, lanes 1 and 2). Signal
intensity differences were observed between chromosomal
bands of the 2 L. donovani strains. Figure 2C shows a pos-
itive control hybridization experiment with the telomeric
probe (CCCTAA)3.
To test the sensitivity of our telomeric probes, we first
hybridized slot blots of L. donovani cell dilutions with a
radiolabeled telomeric probe (see Materials and Methods).
As shown in Figure 3A, we detected as few as to 50 Leish-
mania cells without PCR amplification.
When the L. donovani telomeric PCR was tested on pu-
rified L. donovani DNA and the amplification products were
analyzed by slot-blot hybridizations that used the capture
probe, a strong signal was observed at the maximum dilution
used in this experiment (Figure 3B) equivalent to 1 fg of
DNA ( 5 	 103 cell equivalents).
Leishmania donovani telomeric PCR products were of dif-
ferent sizes when resolved on agarose gels (Figure 4A and
B, isolate 141). Leishmania braziliensis, L. amazonensis, and
a local isolate later identified as L. colombiensis were neg-
ative (Figure 4A and B, lanes 1, 2, and 3, respectively).
Separation of the PCR products by SDS-polyacrylamide gel
electrophoresis produced numerous bands (Figure 5) due to
variations in the numbers of hexamers and octamers per telo-
meric block (Figure 1) and is more evident in Figure 5 be-
cause the PCR products were digested with RsaI endonucle-
ase.
The specificity of our PCR assay was further tested by
means of DNA samples from Old World Leishmania. The
results in Table 1 and Figure 6 indicate that except for L.
infantum KA (143), all L. donovani and L. infantum isolates
were positive. A very weak signal was also observed for
isolate 139, identified as L. infantum, but isolated from a
case of cutaneous leishmaniasis. Of 5 L. major isolates test-
ed, only L. major S1-177 (Figure 6, 149) was positive, with
a ring-type hybridization devoid of signal in the center of
the dot (Figure 6). Of 5 L. tropica isolates assayed, only
isolate 148 was positive. Although identified as L. tropica,
this isolate was obtained from a patient with VL. Leishmania
turinica KXG-2(138) was positive with a ring-type hybrid-
ization similar to isolate L. major 149. The L. donovani telo-
meric PCR assay recognized all New World reference VL
isolates except for 2 L. colombiensis isolates from Venezuela
and 1 Brazilian isolate (Table 2).
Detection of patient samples. The DNA extracted from
blood or bone marrow samples from 3 Indian patients with
VL gave positive results when assayed on dot blots that used
a telomeric probe (data not shown).
All Venezuelan archive samples with confirmed parasito-
logical analysis (Table 3) were positive with our PCR meth-
od, and out of 2 parasitologically negative samples, one was
positive and the other negative (Figure 7).
DISCUSSION
We present a novel PCR assay targeted at L. donovani
telomeric sequences that has sensitivity and specificity for
L. donovani and L. infantum. In patient samples from India,
the telomeric probes detected Leishmania DNA even without
PCR amplification, indicating a high copy number for these
telomeric sequences in Indian Leishmania isolates.16 This
property is currently being evaluated.
Except for one L. infantum isolate, the assay recognized
all 20 Old World VL isolates. In L. major isolates, 1 of 5
isolates was positive with an atypical hybridization signal.
This result was unexpected because we know from our work
(Chiurillo MA and others, unpublished data) and others16,17
that the forward oligonucleotide primer of the PCR assay
should not hybridize to L. major telomeric sequences. We
also observed a single positive result out of 5 L. tropica
isolates tested. This isolate (L. tropica 1095, isolate 148;
Figure 6) was obtained from a patient with VL obtained
during the Gulf war.8 We are currently expanding the number
of L. major and L. tropica reference isolates.
The assay in Venezuela produced the following results: all
reference isolates of L. chagasi or L. infantum were positive;
however, 1 Brazilian and 2 Venezuelan VL isolates were
negative. The 2 negative Venezuelan VL isolates had been
previously identified as L. colombiensis,7 a parasite included
within the Viannia subgenus18 and suspected of being com-
mon in western Venezuela endemic areas (Bonfante R, un-
published data). It is interesting that in one of the endemic
areas, which neighbors a L. colombiensis-endemic area, only
L. donovani-related parasites were detected.
Although good PCR and other molecular assays exist for
detecting L. donovani species,12,19,20 the main advantages of
our assay are as follows: increased specificity compared with
kDNA-based assays21 (Guevara P, unpublished data), little
cross-reactivity with L. major or L. tropica strains, and for
kala-azar, the possibility of using telomeric-derived probes
without further amplification. This level of sensitivity is like-
ly because of the high copy number (per diploid genome)
found for related sequences in L. donovani isolates from In-
dia and Ethiopia.16 The telomeres of L. major have sequence
homology and the block structure17 described for L. dono-
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FIGURE 6. Specificity test of Leishmania donovani telomeric-polymerase chain reaction (PCR) in Old World Leishmania. Dot blots of PCR
products are hybridized with radiolabeled capture oligonucleotide. The identity of isolates is indicated. Plasmodium falciparum and human
breast cancer cell line MCF-7 DNA were used as negative controls.
vani; however, as mentioned above, the primers here hybrid-
ized to regions where L. major has several nucleotide chang-
es.15
Finally, this PCR assay, in combination with the simple
protocol for recovery of Giemsa-stained slides of bone mar-
row, proved useful for the retrospective study of archive ma-
terial. This combination of techniques may prove to be an
excellent epidemiological tool.
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1). Lanes 1–5, parasitologically confirmed samples. Lane 6, DNA from Ld 51.2. Lane 7, negative control from a patient with an unrelated
hematological disease.
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